Skip to main content
. 2021 Feb 1;13(3):553. doi: 10.3390/cancers13030553

Table 1.

Demographic characteristics.

Demographic Characteristics n (%)
Total eligible patients 566 (100)
Total participation rate 201 (35.5)
Mean age: 44.2 years (range 23–74) 201 (100)
Mean age at time of diagnosis 33.7 years (range 20–68) 201 (100)
Mean follow up time to questionnaire 10.6 years (range 2–21) 201 (100)
Histology
Seminoma 101 (50.2)
Non-seminoma 96 (47.8)
Neuro-endocrine 1 (0.5)
Leydig cell tumour (malign) 3 (1.5)
Histology contralateral tumour 7 (3.4)
Seminoma 2 (28.6)
Non-seminoma 4 (57.2)
CIS 1 (14.3)
Tumor stadium
Stage I 103 (51.2)
Stage II 29 (14.4)
Stage III 2 (1)
Stage IV 7 (3.5)
Unknown 60 (29.9)
Primary treatment
Primary orchiectomy a 200 (99.5)
Chemotherapy 1 (0.5)
Orchiectomy for contralateral tumour 7 (3.5)
Secondary
Surveillance 48 (23.9)
Additional therapy
Chemotherapy 96 (47.8)
+RPLND 21 (10.4)
+RT 3 (1.5)
+RPLND & RT 1 (0.5)
+Metastasectomy 3 (1.5)
+RT + Metastasectomy 1 (0.5)
Metastasectomy a 1 (0.5)
Radiotherapy 27 (13.4)
Marital status
Married/registered partnership 116 (57.7)
Relationship, living together 47 (23.4)
Relationship, living apart 13 (6.5)
Single 18 (9)
Divorced 4 (2)
Widow 1 (0.5)
Unknown 2 (1)
Educational level
Secondary school 36 (17.9)
Secondary vocational education 50 (24.9)
Higher professional education/University 115 (57.2)
Country of birth
Netherlands 178 (88.6)
Other (USA 1, Colombia 2, Germany 3, France 1, Indonesia 2, Iran 1, unknown 13) 23 (11.4)

(a) a single patient did not primarily receive an orchiectomy as there was a burned out tumour; presenting with metastasis.